Clinical Scorecard: Can Testosterone Affect Cognitive Function?
At a Glance
Category
Detail
Condition
Testosterone deficiency and its impact on mood and cognitive function
Key Mechanisms
Testosterone therapy may improve mood and specific cognitive outcomes, particularly in men with low testosterone levels.
Target Population
Adult men aged 18 to 85 years, including healthy eugonadal men, older adults with hypogonadism, men with treatment-resistant depression, and patients with mild Alzheimer's disease.
Care Setting
Endocrinologic supervision in clinical practice.
Key Highlights
Testosterone therapy showed modest benefits for mood and select cognitive outcomes.
Significant reductions in depressive symptoms were noted in men with treatment-resistant depression.
Cognitive improvements were domain-specific, particularly in verbal memory and visuospatial processing.
Quality of life and sexual function improved consistently across studies.
Testosterone therapy was generally well tolerated with mostly mild adverse events.
Guideline-Based Recommendations
Diagnosis
Assess testosterone levels in men with depressive symptoms or cognitive concerns.
Management
Consider testosterone therapy as a complementary strategy for men with documented androgen deficiency.
Monitoring & Follow-up
Monitor hematocrit levels and other potential adverse effects during therapy.
Risks
Be aware of potential increases in aggression and mixed anxiety outcomes with supraphysiologic dosing.
Patient & Prescribing Data
Men with confirmed androgen deficiency, particularly those experiencing depressive symptoms or cognitive decline.
Testosterone therapy should be implemented under endocrinologic supervision with appropriate monitoring.
Clinical Best Practices
Reserve testosterone therapy for men with documented androgen deficiency.
Implement therapy under endocrinologic supervision.
Conduct larger, longer-term randomized trials to clarify benefits and risks.
